VGVAPG increased the migration of melanoma cells and the generation of elastin-derived peptides, enhancing the expression of elastin-degrading MMP-2 and MMP-3 through binding to galectin-3 and EBP receptors. This evidence concerns the gene MMP2 and melanoma.